Table 1. Baseline clinical characteristics for the enrolled patients: gender, age, hepatobiliary phase hepatic gadolinium concentration, fat fraction, relaxation times, and plasma bilirubin concentration in three liver disease groups.
| Characteristics | Disease group | ||
|---|---|---|---|
| No | Acute | Chronic | |
| Gender (male/female) | 32/40 | 14/7 | 80/29 |
| Age (years), mean ± SD | 53±16&,&& | 65±15& | 61±11&& |
| [Gd] (µmol/L), mean ± SD | 0.52±0.19+,++ | 0.28±0.16+ | 0.31±0.12++ |
| Fat fraction (%), mean ± SD | 7.1±5.3 | 6.8±6.7 | 7.9±6.0 |
| Relaxation times R2* (ms−1), mean ± SD | 1.5 T (n=44): 37±13 | 1.5 T (n=12): 35±16 | 1.5 T (n=70): 37±14 |
| 3 T (n=28): 56±34 | 3 T (n=9): 43±23 | 3 T (n=39): 51±26 | |
| [Bilirubin] (µmol/L), mean ± SD | 7.8±3.6#,## | 29.0±23.0# | 20.3±26.5## |
Pairwise significant differences are marked with: &, P=0.007 (no vs. acute); &&, P=0.002 (no vs. chronic); +, P<0.001 (no vs. acute); ++, P<0.001 (no vs. chronic); #, P<0.001 (no vs. acute); ##, P<0.001 (no vs. chronic). SD, standard deviation; [Gd], gadolinium concentration.